Decreased ovarian response to human menopausal gonadotropin caused by subcutaneously administered gonadotropin-releasing hormone agonist
- 1 March 1987
- journal article
- case report
- Published by Elsevier in Fertility and Sterility
- Vol. 47 (3), 512-515
- https://doi.org/10.1016/s0015-0282(16)59065-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Comparison of the efficacy of subcutaneous and nasal spray Buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancerFertility and Sterility, 1986
- Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppressionFertility and Sterility, 1986
- Therapeutic Applications of Luteinizing-Hormone-Releasing Hormone and Its AnalogsAnnals of Internal Medicine, 1985
- Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophinsBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- INHIBITION OF HUMAN GRANULOSA CELL PROGESTERONE SECRETION BY A GONADOTROPIN-RELEASING HORMONE AGONISTJournal of Clinical Endocrinology & Metabolism, 1982